Tetrameric Complexes of Human Histocompatibility Leukocyte Antigen (HLA)-G Bind to Peripheral Blood Myelomonocytic Cells

The nonclassical MHC class I molecule human histocompatibility leukocyte antigen (HLA)-G is selectively expressed on fetal trophoblast tissue at the maternal–fetal interface in pregnancy. It has long been suggested that HLA-G may inhibit maternal natural killer (NK) cells through interaction with particular NK cell receptors (KIRs). To investigate interactions of HLA-G, we constructed phycoerythrin-labeled tetrameric complexes of HLA-G refolded with a self-peptide. These HLA-G tetramers failed to bind to NK cells and cells transfected with CD94/NKG2 and killer immunoglobulin-like NK receptors. In contrast, HLA-G tetramers did bind to peripheral blood monocytes, staining a CD16+CD14mid subset with greater intensity. On transfectants, HLA-G tetramers bound to inhibitory immunoglobulin-like transcript (ILT)2 and ILT4 receptors. However, staining in the presence of antibodies reactive with ILT receptors revealed that the interaction of HLA-G tetramers with blood monocytes was largely due to binding to ILT4. These results suggest that the primary role of HLA-G may be the modulation of myelomonocytic cell behavior in pregnancy.

[1]  M. Colonna,et al.  Human myeloid cells express an activating ILT receptor (ILT1) that associates with Fc receptor gamma-chain. , 1999, Journal of immunology.

[2]  M. Colonna,et al.  Cutting Edge: Human Myeloid Cells Express an Activating ILT Receptor (ILT1) That Associates with Fc Receptor γ-Chain , 1999, The Journal of Immunology.

[3]  C. Maliszewski,et al.  The MHC class I binding proteins LIR‐1 and LIR‐2 inhibit Fc receptor‐mediated signaling in monocytes , 1998, European journal of immunology.

[4]  S. Rowland-Jones,et al.  Oligoclonal Expansions of CD8+ T Cells in Chronic HIV Infection Are Antigen Specific , 1998, The Journal of experimental medicine.

[5]  G. Ogg,et al.  HLA-peptide tetrameric complexes. , 1998, Current opinion in immunology.

[6]  O. Majdic,et al.  Identification of CD68+lin- peripheral blood cells with dendritic precursor characteristics. , 1998, Journal of immunology.

[7]  Jun Wu,et al.  Association of DAP12 with activating CD94/NKG2C NK cell receptors. , 1998, Immunity.

[8]  Michele Cilli,et al.  p49, a putative HLA class I‐specific inhibitory NK receptor belonging to the immunoglobulin superfamily , 1998, European journal of immunology.

[9]  D. Goodlett,et al.  HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. , 1998, Journal of immunology.

[10]  M. Llano,et al.  HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  G. Ogg,et al.  Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. , 1998, Journal of immunology.

[12]  J. Coligan,et al.  Recognition of Human Histocompatibility Leukocyte Antigen (HLA)-E Complexed with HLA Class I Signal Sequence–derived Peptides by CD94/NKG2 Confers Protection from Natural Killer Cell–mediated Lysis , 1998, The Journal of experimental medicine.

[13]  J. Bell,et al.  HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C , 1998, Nature.

[14]  A. McMichael,et al.  TAP- and tapasin-dependent HLA-E surface expression correlates with the binding of an MHC class I leader peptide , 1998, Current Biology.

[15]  M. Colonna,et al.  A Common Inhibitory Receptor for Major Histocompatibility Complex Class I Molecules on Human Lymphoid and Myelomonocytic Cells , 1997, The Journal of experimental medicine.

[16]  M. Kubin,et al.  A family of human lymphoid and myeloid Ig-like receptors, some of which bind to MHC class I molecules. , 1997, Journal of Immunology.

[17]  K. Austen,et al.  Molecular identification of a novel family of human Ig superfamily members that possess immunoreceptor tyrosine-based inhibition motifs and homology to the mouse gp49B1 inhibitory receptor. , 1997, Journal of immunology.

[18]  D. Geraghty,et al.  HLA‐G recognition by human natural killer cells. Involvement of CD94 both as inhibitory and as activating receptor complex , 1997, European journal of immunology.

[19]  M. Kubin,et al.  A novel immunoglobulin superfamily receptor for cellular and viral MHC class I molecules. , 1997, Immunity.

[20]  S. Hiby,et al.  Evaluation of trophoblast HLA-G antigen with a specific monoclonal antibody. , 1997, Tissue antigens.

[21]  L. Lanier,et al.  CD94/NKG2 is the predominant inhibitory receptor involved in recognition of HLA-G by decidual and peripheral blood NK cells. , 1997, Journal of immunology.

[22]  Eric O Long,et al.  A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors , 1997, Current Biology.

[23]  I. Melero,et al.  The CD94/NKG2-A inhibitory receptor complex is involved in natural killer cell-mediated recognition of cells expressing HLA-G1. , 1997, Journal of immunology.

[24]  Manfred Brockhaus,et al.  A Novel Inhibitory Receptor (ILT3) Expressed on Monocytes, Macrophages, and Dendritic Cells Involved in Antigen Processing , 1997, The Journal of experimental medicine.

[25]  A. McMichael,et al.  The human major histocompatibility complex class Ib molecule HLA‐E binds signal sequence‐derived peptides with primary anchor residues at positions 2 and 9 , 1997, European journal of immunology.

[26]  M. Colonna,et al.  Cloning of novel immunoglobulin superfamily receptors expressed on human myeloid and lymphoid cells: Structural evidence for new stimulatory and inhibitory pathways , 1997, European journal of immunology.

[27]  H. Rammensee,et al.  Human Histocompatibility Leukocyte Antigen (HLA)-G Molecules Inhibit NKAT3 Expressing Natural Killer Cells , 1997, The Journal of experimental medicine.

[28]  L. Lanier,et al.  Arousal and inhibition of human NK cells , 1997, Immunological reviews.

[29]  O. Mandelboim,et al.  Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells , 1996, Science.

[30]  H. Ziegler-Heitbrock,et al.  Heterogeneity of human blood monocytes: the CD14+ CD16+ subpopulation. , 1996, Immunology today.

[31]  T. Guillaudeux,et al.  Placental Expression of HLA Class I Genes , 1996, American journal of reproductive immunology.

[32]  H. Rammensee,et al.  Nonclassical HLA-G molecules are classical peptide presenters , 1996, Current Biology.

[33]  Y. W. Loke,et al.  Human uterine natural killer cells. , 1996, Natural immunity.

[34]  J. Bajorath,et al.  The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. , 1995, Immunity.

[35]  K. Lim,et al.  Human placental HLA-G expression is restricted to differentiated cytotrophoblasts. , 1995, Journal of immunology.

[36]  P. Lipsky,et al.  Human peripheral blood dendritic cell subsets. Isolation and characterization of precursor and mature antigen-presenting cells. , 1994, Journal of immunology.

[37]  R. Steinman,et al.  Human blood contains two subsets of dendritic cells, one immunologically mature and the other immature. , 1994, Immunology.

[38]  M. Palmer,et al.  Human trophoblast and the choriocarcinoma cell line BeWo express a truncated HLA Class I molecule. , 1990, Journal of immunology.